Antibody–Drug Conjugates for Immunology
The application of antibody–drug conjugates (ADCs) to fields outside of oncology is increasing but is still relatively uncommon. A recent publication describes the conjugation of glucocorticoid receptor modulators to antibodies as a means of improving the separation between desired anti-inflammatory...
Gespeichert in:
| Veröffentlicht in: | Journal of medicinal chemistry 2022-03, Vol.65 (6), p.4496-4499 |
|---|---|
| 1. Verfasser: | |
| Format: | Artikel |
| Sprache: | eng |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| Zusammenfassung: | The application of antibody–drug conjugates (ADCs) to fields outside of oncology is increasing but is still relatively uncommon. A recent publication describes the conjugation of glucocorticoid receptor modulators to antibodies as a means of improving the separation between desired anti-inflammatory activity and unwanted systemic side effects. |
|---|---|
| ISSN: | 0022-2623 1520-4804 |
| DOI: | 10.1021/acs.jmedchem.2c00339 |